New Jersey A4915 requires health insurance coverage for early-stage kidney disease screening without cost sharing.

New Jersey A4915 mandates that health insurers and health benefits plans cover early-stage kidney disease screening without cost sharing. This includes group health insurance policies, individual health insurance policies, health service corporation contracts, hospital service corporation contracts, medical service corporation contracts, and health benefits plans or contracts under various New Jersey health programs. Early-stage kidney disease screening is defined as either a blood test to determine an individual’s estimated glomerular filtration rate or a urine albumin-creatinine ratio test.

New Jersey A4915 requires health insurance coverage for early-stage kidney disease screening without cost sharing.

New Jersey A4915 mandates that health insurers and health benefits plans cover early-stage kidney disease screening without cost sharing. This includes group health insurance policies, individual health insurance policies, health service corporation contracts, hospital service corporation contracts, medical service corporation contracts, and health benefits plans or contracts under various New Jersey health programs. Early-stage kidney disease screening is defined as either a blood test to determine an individual’s estimated glomerular filtration rate or a urine albumin-creatinine ratio test.